AccuraGen
Latest round
- Series B
Last raised
- Jun 2016
Total raised
- $40M
Investors
- 5
About AccuraGen
Founded in 2013 in Menlo Park, US, AccuraGen develops liquid biopsy technologies aimed at improving cancer diagnostics.AccuraGen, Inc. specializes in innovative liquid biopsy solutions that facilitate non-invasive cancer diagnostics through advanced DNA and RNA sequencing. The company's core technology employs rolling-circle amplification for accurate genetic analysis, critical for personalized treatment plans and monitoring minimal residual disease (MRD).AccuraGen generates revenue through partnerships and collaborations with medical institutions and research organizations, integrating its liquid biopsy technology into clinical settings. The revenue model includes service agreements and sales of diagnostic assays, sold primarily on a B2B basis to healthcare providers for patient testing.AccuraGen aims to enhance its market presence by launching new liquid biopsy products aimed at improving diagnostic accuracy and patient outcomes.
Who invested in AccuraGen
5 investors across 1 round
See all investors in AccuraGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 1, 2016
Amount
$40M
Investors
Questions about AccuraGen
Who invested in AccuraGen?
AccuraGen has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AccuraGen raised?
AccuraGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AccuraGen last raise money?
AccuraGen's most recent round on record is a Series B, in Jun 2016.
What does AccuraGen do?
Founded in 2013 in Menlo Park, US, AccuraGen develops liquid biopsy technologies aimed at improving cancer diagnostics.
Where is AccuraGen headquartered?
AccuraGen is headquartered in Menlo Park, US.
Which VCs invest in companies like AccuraGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at AccuraGen's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like AccuraGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.